Global, Regional, and National Burden of Valvular Heart Disease, 1990 to 2021
Journal of the American Heart Association · 17.12.2024 · 13 (24)
DOI: 10.1161/jaha.124.037991 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 17.12.2024. Verfasst von Qin-Fen Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Medical Care Center The First Affiliated Hospital of Wenzhou Medical University Wenzhou Zhejiang China. Hauptthemen laut MEDLINE: Heart Valve Diseases. Die Arbeit wurde bisher 97-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Valvular heart disease poses an escalating global health challenge with an increasing impact on mortality and disability. This study aims to comprehensively analyze the global burden of valvular heart disease. Methods and Results Using the Global Burden of Disease 2021 data, we analyzed the prevalence and disability‐adjusted life years, examining implications across demographics and geographic regions. In 2021, an estimated 54.8 million (95% uncertainty interval [UI], 43.3–67.6) cases of rheumatic heart disease, 13.3 million (95% UI, 11.4–15.2) cases of nonrheumatic calcific aortic valve disease (CAVD), and 15.5 million (95% UI, 14.5–16.7) cases of nonrheumatic degenerative mitral valve disease (DMVD) were reported globally. Despite the rising prevalence, disability‐adjusted life years declined between 1991 and 2021. Among individuals aged 70 years or older, the age‐standardized prevalences were 1803.6 per 100 000 (95% UI, 1535.5–2055.7) for CAVD and 2148.9 per 100 000 (95% UI, 2001.4–2310.1) for DMVD. Sub‐Saharan Africa had the highest age‐standardized prevalence for rheumatic heart disease; Conversely, high‐income regions led in CAVD and DMVD prevalence. Rheumatic heart disease had the highest age‐standardized prevalence of 1184.2 per 100 000 (95% UI, 932.4–1478.2) in low Socio‐Demographic Index (SDI) regions, whereas CAVD peaked at 349.8 per 100 000 (95% UI, 303.6–395.8) in high SDI regions. The most substantial increases in age‐standardized prevalences of CAVD from 1990 to 2021 occurred in the middle SDI and low‐middle SDI regions. A parallel trend was noted for DMVD.
Conclusions
Rheumatic heart disease remains a significant burden in low SDI regions, whereas CAVD and DMVD pose challenges in high SDI regions with aging populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Care Center The First Affiliated Hospital of Wenzhou Medical University Wenzhou Zhejiang China.
- Institute of Aging, Key Laboratory of Alzheimer's Disease of Zhejiang Province, Zhejiang Provincial Clinical Research Center for Mental Disorders, School of Mental Health and the Affiliated Kangning Hospital, Wenzhou Me…
- Department of Cardiovascular Medicine, The Heart Center The First Affiliated Hospital of Wenzhou Medical University Wenzhou Zhejiang China.
- University of Waterloo Waterloo Canada.
- Wenzhou Medical University Renji College Wenzhou China.
- Department of Cardiology Ningbo No. 2 Hospital Wenzhou Zhejiang China.
ORCID-Profile: Qin-Fen Chen, Shanzhen Shi, Chenyang Liu, Weihong Lin, Yangdi Peng, Xiao-Dong Zhou
Zitieren
APA
Chen, Q. F., Shi, S., Wang, Y. F., Shi, J., Liu, C., Xu, T., Ni, C., Zhou, X., Lin, W., Peng, Y., & Zhou, X. D. (2024). Global, Regional, and National Burden of Valvular Heart Disease, 1990 to 2021. Journal of the American Heart Association, 13(24). https://doi.org/10.1161/jaha.124.037991
Vancouver
Chen QF, Shi S, Wang YF, Shi J, Liu C, Xu T, et al. Global, Regional, and National Burden of Valvular Heart Disease, 1990 to 2021. Journal of the American Heart Association. 2024;13(24). doi:10.1161/jaha.124.037991
BibTeX
@article{Chen2024,
author = {Chen, Qin-Fen and Shi, Shanzhen and Wang, Yu-Fei and Shi, Jingjing and Liu, Chenyang and Xu, Tiancheng and Ni, Chao and Zhou, Xi and Lin, Weihong and Peng, Yangdi and Zhou, Xiao-Dong},
title = {Global, Regional, and National Burden of Valvular Heart Disease, 1990 to 2021},
journal = {Journal of the American Heart Association},
year = {2024},
volume = {13},
number = {24},
doi = {10.1161/jaha.124.037991}
}
EUVIMED